TCL Archive Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival December 27, 2013
TCL Archive Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum January 8, 1993